News & Events

elminda Announces approval of BNA™ Analysis System by the Israeli Ministry of Health

Herzliya – elminda Ltd. announced today that the Israeli Ministry of Health has approved registration of the company’s BNA™ Analysis System as a medical device for the assessment of brain function. Brain Network Activity (BNA™) combines non-invasive, multi-channel EEG technology with sophisticated signal processing and analysis algorithms to measure patterns of brain networks activated during specific brain processes and deliver both quantitative and qualitative insights into brain functionality. The BNA™ output allows healthcare providers to assess a patient’s functional brain network activity and compare it with functional network activity of healthy brains. BNA™ is currently cleared for 14 to 24 year-olds, and the company is conducting additional research activities to further expand the indicated age group.

Back to top